News

Leandro Cerchietti, M.D., researches lymphoma at Weill Cornell Medicine

2016 Mar 09

New approach to treating aggressive B-cell lymphomas

Leandro Cerchietti, M.D., has identified a potential new strategy for the treatment of aggressive diffuse large B-cell lymphomas (DLBCL) called double and triple hit lymphomas. Read more

Cornell president Elizabeth Garrett died of colon cancer

2016 Mar 08

Cancer research fund set up at Weill Cornell in honor of Garrett

A memorial fund for Cornell President Elizabeth Garrett has been set up to fund colon cancer research at the Meyer Cancer Center. Read more

2016 Mar 07

Cancer and virtual reality

Olivier Elemento, Ph.D., discusses the use of virtual reality in cancer research. Read more

Edouard Mullarky, Ph.D., of the lab of Lewis Cantley

2016 Mar 07

Team finds new approach to curbing cancer cell growth

New drug targeting the serine pathway could be used to treat certain types of breast cancer, lung cancer and melanoma. Read more

Denise Minton, Ph.D., has identified a gene that could transform kidney cancer treatment

2016 Mar 07

Clearing a hurdle: Lab IDs potential target in kidney cancer

The lab of Lorraine Gudas, Ph.D., has identified a gene that may provide a new, super specific target for drugs that could stop kidney cancer progression in its tracks. Read more

2016 Mar 03

Palbociclib sensitizes myeloma cells to immunomodulatory drugs

Selina Chen-Kiang, Ph.D., discusses the effect of immunomodulatory drugs on myeloma cells Read more

2016 Feb 29

New York City: En Route to a Bio Cluster

Editorial about New York City's life sciences scene mentions Lewis Cantley, Laurie Glimcher, and the Meyer Cancer Center. Read more

2016 Feb 24

The cancer campaign that got personal

Patient Anne Glauber discusses life with pancreatic cancer, and her doctor, Allyson Ocean. Read more

2016 Feb 24

Here's how virtual reality could help doctors treat cancer

A new Oculus Rift program created in the Elemento Lab lets researchers hunt for DNA mutations in 3D Read more

2016 Feb 23

Dean Laurie Glimcher to lead Dana-Farber Cancer Institute

Dr. Laurie H. Glimcher has been named president and chief executive officer of the Dana-Farber Cancer Institute in Boston. Read more

Dr. Susan Pannullo with brain cancer patient Ada Carmona

2016 Feb 22

“Nobody Else Understood”

A woman with a debilitating meningioma tumor finds relief – and understanding – at Weill Cornell. Read more

2016 Feb 18

Biologists urged to hug a preprint

Harold Varmus, M.D., discusses the idea of biomedical researchers releasing their work online before peer review and journal publication. Read more

Art Sedrakyan, M.D., Ph.D., found that nearly one in four women with early-stage breast cancer who undergo a partial mastectomy will need a second surgery within 90 days

2016 Feb 17

Breast cancer surgical option carries heightened risk of repeat surgery

Nearly one in four women with early-stage breast cancer who undergo a partial mastectomy will need a second surgery within 90 days. Read more

2016 Feb 17

The Treatment Paradigm for Gastrointestinal Cancers

Manish A. Shah, M.D., discusses how BBI608 might fit into the treatment paradigm for gastric and gastroesophageal junction cancer. Read more

2016 Feb 16

Chemo-related hair loss treatment works one follicle at a time

Tessa Cigler, M.D., discusses cold cap treatment to prevent hair loss during chemotherapy for breast cancer. Read more

2016 Feb 16

Partnering up to pursue non-invasive prostate cancer detection

Senior Scientific, LLC, has established a research collaboration with Weill Cornell Medicine to investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers. Read more

2016 Feb 15

Among keys to curing cancer, academic medical centers loom large

Dean Laurie Glimcher pens a guest piece about the role academic medical centers will have in realizing Vice President Joe Biden's "moonshot to cure cancer" campaign. Read more

2016 Feb 10

Stem cell transplant in myeloma: Necessity or choice?

Stem cell transplant is a tool, not a necessity when it comes to multiple myeloma, argues Tomer Mark, M.D., MSc. Read more

2016 Feb 09

Precision medicine unleashed

Mark Rubin, M.D., discusses the EXaCT-1 exome sequencing test for cancer developed at the Institute of Precision Medicine. Read more

2016 Feb 08

Sequencing reveals molecular underpinnings of aggressive prostate cancer subtype

A team of researchers led by Himisha Beltran, M.D., discovered the genetic, epigenetic and molecular features that underlie neuroendocrine prostate cancer. Read more

News

New approach to treating aggressive B-cell lymphomas

Cancer research fund set up at Weill Cornell in honor of Garrett

Cancer and virtual reality

Team finds new approach to curbing cancer cell growth

Clearing a hurdle: Lab IDs potential target in kidney cancer

Palbociclib sensitizes myeloma cells to immunomodulatory drugs

New York City: En Route to a Bio Cluster

The cancer campaign that got personal

Here's how virtual reality could help doctors treat cancer

Dean Laurie Glimcher to lead Dana-Farber Cancer Institute

“Nobody Else Understood”

Biologists urged to hug a preprint

Breast cancer surgical option carries heightened risk of repeat surgery

The Treatment Paradigm for Gastrointestinal Cancers

Chemo-related hair loss treatment works one follicle at a time

Partnering up to pursue non-invasive prostate cancer detection

Among keys to curing cancer, academic medical centers loom large

Stem cell transplant in myeloma: Necessity or choice?

Precision medicine unleashed

Sequencing reveals molecular underpinnings of aggressive prostate cancer subtype

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters